Peer-Reviewed Publication
Am J Pathol2025;195(12):2400-2410.December 1, 2025Journal Article

Cross-Modality Learning for Predicting Immunohistochemistry Biomarkers from Hematoxylin and Eosin-Stained Whole Slide Images.

Amit Das1, Naofumi Tomita2, Kyle J Syme3, Weijie Ma3, Paige O'Connor3, Kristin N Corbett3, Bing Ren3, Xiaoying Liu3, Saeed Hassanpour4
1Department of Computer Science, Dartmouth College, Hanover, New Hampshire.
2Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
3Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
4Department of Computer Science, Dartmouth College, Hanover, New Hampshire; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. Electronic address: saeed.hassanpour@dartmouth.edu.

Abstract

Hematoxylin and eosin (H&E) staining is a cornerstone of pathologic analysis, offering reliable visualization of cellular morphology and tissue architecture for cancer diagnosis, subtyping, and grading. Immunohistochemistry (IHC) staining provides insights by detecting specific proteins within tissues, enhancing diagnostic accuracy, and improving treatment planning. However, IHC staining is costly…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.